Skip to content

SI-BONE, Inc. SIBN Lessee Operating Lease Liability Undiscounted Excess Amount

Lessee Operating Lease Liability Undiscounted Excess Amount at other companies

Globus Medical logo
Globus MedicalGMED
IAR
Integra LifeSciencesIART

Other financials

Income statement

See full
Revenue$52.6M+11.2%
Gross profit$41.9M+11.3%
Operating income-$5.1M+31.9%
Net income-$4.3M+33.8%
EPS (diluted)-$0.10+33.3%

Balance sheet

See full
Cash & equivalents$33.5M-18.6%
Total debt$42.9M+15.6%
Total equity$178.9M+7.0%
Total assets$242.7M+6.8%

Cash flow

See full
Operating cash flow-$2.4M+51.9%
CapEx$1.1M-48.0%
Free cash flow-$3.4M+50.8%

Valuation

See full
Market cap$743.29M+6.4%
Enterprise value$752.71M+8.4%
P/S3.6×-0.4×

Profitability

See full
Gross margin79.6%+0.3pp
Operating margin-9.7%-3.0pp
Net margin-8.1%-2.6pp
FCF margin-2.9%-1.2pp

Returns & leverage

See full
Return on equity-9.6%-2.7pp
Debt / equity0.2×0.0×
Current ratio10×+1.5×

Where this comes from

Reported directly by SI-BONE, Inc. in its filing.

Tagged under the XBRL concept us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount.

The official record: SI-BONE, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about SI-BONE, Inc.'s lessee operating lease liability undiscounted excess amount.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is SI-BONE, Inc.'s lessee operating lease liability undiscounted excess amount?
SI-BONE, Inc. (SIBN) reported lessee operating lease liability undiscounted excess amount of $7.3M in Q1 2026.
How has SI-BONE, Inc.'s lessee operating lease liability undiscounted excess amount changed year-over-year?
SI-BONE, Inc.'s lessee operating lease liability undiscounted excess amount increased by 8197.7% year-over-year, from $88K to $7.3M.